investment

Thermo Fisher’s $10 Billion Acquisition: Clinical Trial DX and Investment Strategy

Thermo Fisher's acquisition of Clario leads the clinical trial DX market. This guide details the strategic significance of M&A, market trends, implications for investors, and lessons to be learned by Japanese companies.

2025.11.04

未分類

Huntington Cadence $7.4 Billion M&A: The Depths of Financial Restructuring

Huntington's acquisition of Cadence is a major M&A case in the U.S. financial industry: a detailed analysis of the strategic value of the $7.4 billion deal, its market impact, and future integration challenges.

2025.11.04

未分類

India IPO Market: $5 Billion Booming in 2025 and Deep Dive into Investment Opportunities

Amid global economic uncertainty, the Indian IPO market is expected to boom to a record $5 billion in 2025. An international financial journalist analyzes the background to this growth, the perspectives of global investors, and its impact on M&A.

2025.10.19

未分類